Valuation : CVRx, Inc.

Market Cap 78.59M 67.67M 63.54M 58M 109M 7.48B 110M 753M 293M 3.79B 295M 289M 12.56B P/E 2026 *
-1.46x
P/E 2027 * -1.54x
Enterprise Value 89.1M 76.71M 72.03M 65.75M 124M 8.48B 124M 854M 332M 4.3B 335M 327M 14.23B EV / Sales 2026 *
1.51x
EV / Sales 2027 * 1.84x
Free-Float
80.18%
Yield 2026 *
-
Yield 2027 * -
1 day-2.20%
1 week-8.57%
Current month-44.35%
1 month-44.35%
3 months-46.96%
6 months-64.79%
Current year-59.44%
1 week 2.81
Extreme 2.81
3.42
1 month 2.2
Extreme 2.2
6
Current year 2.2
Extreme 2.2
9.84
1 year 2.2
Extreme 2.2
11.3
3 years 2.2
Extreme 2.2
33.14
5 years 2.2
Extreme 2.2
33.14
10 years 2.2
Extreme 2.2
33.14
Manager TitleAgeSince
Chief Executive Officer 60 12/02/2024
Director of Finance/CFO 43 01/10/2020
Chief Operating Officer 57 11/08/2025
Director TitleAgeSince
Director/Board Member 61 01/10/2008
Director/Board Member 57 01/07/2020
Director/Board Member 52 01/07/2020
Date Insider Type Main position Quantity % Market Cap. Importance
13/8/26 Buy

Chief Operating Officer

26,223 0.0988%
12/8/26 Sell

Chief Operating Officer

-1,309 0.0049%
1/6/26
Treo Ventures LLC
OtherCompany 0 0% -
Change 5-day change 1-year change 3-year change Capi.($)
-2.20%-8.57%-62.74%-83.40% 78.59M
+0.46%-0.18%+19.91%+22.18% 12.67B
-1.41%-0.45%+16.36%+28.13% 7.03B
-1.05%-6.75%+48.66%+28.56% 6.32B
-0.90%-0.55% - - 5.64B
-1.20%-6.96%-13.79%+45.61% 5.14B
-1.18%+2.00%-30.61%-23.99% 3.89B
-0.70%+5.49%+45.04%-19.85% 2.08B
+0.33%+11.07%-3.06%+132.43% 1.77B
-1.57%+3.14%+48.24%-13.31% 1.62B
Average -0.96%+0.68%+7.56%+12.93% 4.62B
Weighted average by Cap. -0.66%-1.01%+15.92%+23.78%

Financials

2026 *2027 *
Net sales 58.85M 50.67M 47.58M 43.43M 81.59M 5.6B 82.18M 564M 219M 2.84B 221M 216M 9.4B 66.18M 56.98M 53.5M 48.84M 91.75M 6.3B 92.41M 634M 247M 3.19B 248M 243M 10.57B
Net income -53.45M -46.02M -43.21M -39.45M -74.1M -5.09B -74.63M -512M -199M -2.58B -201M -196M -8.54B -52.14M -44.89M -42.15M -38.47M -72.28M -4.96B -72.8M -499M -194M -2.52B -196M -191M -8.33B
Net Debt 10.5M 9.04M 8.49M 7.75M 14.56M 999M 14.67M 101M 39.15M 507M 39.44M 38.58M 1.68B 42.94M 36.97M 34.71M 31.69M 59.53M 4.09B 59.95M 411M 160M 2.07B 161M 158M 6.86B
Logo CVRx, Inc.
CVRx, Inc. is a commercial-stage medical device company. The Company is focused on developing, manufacturing and commercializing advanced neuromodulation solutions for patients with cardiovascular diseases. The Company's integrated platform technology, Barostim, is designed to leverage the power of the brain and nervous system to address the imbalance of the autonomic nervous system (ANS), which causes heart failure with reduced ejection fraction (HFrEF) and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy (BAT) by sending imperceptible and persistent electrical pulses to baroreceptors located in the wall of the carotid artery to signal the brain to modulate cardiovascular function. Barostim is a minimally invasive neuromodulation device that consists of two implantable components, an implantable pulse generator (IPG) and a stimulation lead, and is programmed by a wireless clinician-controlled programmer that communicates with the IPG.
Employees
223
Date Price Change Volume
01/09/26 USD 2.870 -2.71% 344,891
28/08/26 USD 2.950 -2.96% 497,116
27/08/26 USD 3.040 -7.03% 449,034
26/08/26 USD 3.270 -2.97% 884,492
25/08/26 USD 3.370 +6.98% 1,123,956
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
2.950USD
Average target price
4.583USD
Spread / Average Target
+55.37%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CVRX Stock